Home › Immunoglobulin Light-chain Amyloidosis › Connecticut › New Haven
Immunoglobulin Light-chain Amyloidosis clinical trials in New Haven, CT
3 studies for Immunoglobulin Light-chain Amyloidosis are looking for participants at sites in and around New Haven (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study to Evaluate the Efficacy and Safety of Belantamab Mafodotin in Combination With Cyclophosphamide, Bortezomib, and Dexamethasone in Adult Participants With Newly Diagnosed Amyloid Light Chain (AL) Amyloidosis
RecruitingPhase 2
- GSK Investigational Site, New Haven
Elranatamab in Patients With Relapsed or Refractory AL Amyloidosis
RecruitingPhase 1/2
- Yale University, New Haven
Comparing Dara-VCD Chemotherapy Plus Stem Cell Transplant to Dara-VCD Chemotherapy Alone for People Who Have Newly Diagnosed AL Amyloidosis
RecruitingPhase 3
- Yale University, New Haven
- Yale-New Haven Hospital North Haven Medical Center, North Haven · 7 mi away
- Smilow Cancer Hospital-Derby Care Center, Derby · 8 mi away
- and 1 more
Immunoglobulin Light-chain Amyloidosis trials in other cities
- Boston, MA8 studies
- Rochester, MN5 studies
- Durham, NC4 studies
- New York City, NY4 studies
- Columbus, OH3 studies
- Cleveland, OH3 studies
- Nashville, TN3 studies
- Salt Lake City, UT3 studies
Other studies in New Haven
- Non-Small Cell Lung Cancer40 studies
- Breast Cancer38 studies
- Cancer (all types)35 studies
- Lung Cancer24 studies
- Colorectal Cancer23 studies
- Head and Neck Squamous Cell Carcinoma22 studies
- Metastatic Cancer22 studies
- Prostate Cancer22 studies
- Ovarian Cancer20 studies
- Opioid Overdose19 studies
- Acute Myeloid Leukemia18 studies
- Alcohol Use Disorder (AUD)18 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.